How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Advanced Acid-resistant Capsules Market
- By Material Type: Hydroxypropyl Methylcellulose (HPMC), Gelatin, Pullulan, Polyvinyl Alcohol (PVA), Starch-based
- By Capsule Form: Hard Capsules, Soft Capsules
- By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Veterinary
- By Release Mechanism: Enteric-coated, Delayed-release, Sustained-release, Immediate-release
- By End-user: Pharmaceutical Manufacturers, Nutraceutical Manufacturers, Contract Manufacturing Organizations (CMOs)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Hydroxypropyl Methylcellulose (HPMC) leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Advanced Acid-resistant Capsules Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Material Type 5
Capsule Form 2
Application 4
Release Mechanism 4
End-user 3
Companies profiled
Capsugel (Lonza Group)
Evonik Industries AG
BASF SE
Colorcon Inc.
Shin-Etsu Chemical Co. Ltd.
JRS Pharma
Aenova Group
Patheon (Thermo Fisher Scientific)
HPMC India
Ashland Global Holdings Inc.
Roquette Frères
Kerry Group
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Capsugel (Lonza Group)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Evonik Industries AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Colorcon Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Shin-Etsu Chemical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →JRS Pharma
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Aenova Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Patheon (Thermo Fisher Scientific)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →HPMC India
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Ashland Global Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Roquette Frères
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Kerry Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →FMC Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Suzhou Sunway Biotech Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Akina
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,400M by 2033 · 10.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Hydroxypropyl Methylcellulose (HPMC)50.2
- Gelatin13.7
- Pullulan13.7
- Polyvinyl Alcohol (PVA)15.5
- Starch-based6.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,111M → $2,245M · 9.2%
Europe$774.7M → $1,573M · 9.3%
Asia Pacific$707.3M → $1,539M · 10.2%
Latin America$437.8M → $871.4M · 9.0%
Middle East and Africa$336.8M → $792.0M · 11.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.292026
10.312027
10.322028
10.322029
10.352030
10.352031
10.352032
10.382033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Capsugel (Lonza Group)22.2
- Evonik Industries AG19.0
- BASF SE7.3
- Colorcon Inc.10.5
- Shin-Etsu Chemical Co. Ltd.7.7
- JRS Pharma5.4
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type21.6%
Capsule Form27.5%
Application10.6%
Release Mechanism16.1%
End-user24.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.0
- Europe22.4
- Asia Pacific21.9
- Latin America12.4
- Middle East and Africa11.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Capsugel (Lonza Group) | 94 | 92 | 84 | 84 | 89 | 83 | 88 |
| Evonik Industries AG | 72 | 88 | 93 | 93 | 85 | 82 | 86 |
| BASF SE | 78 | 75 | 73 | 69 | 86 | 81 | 77 |
| Colorcon Inc. | 72 | 62 | 68 | 58 | 62 | 57 | 63 |
| Shin-Etsu Chemical Co. Ltd. | 71 | 70 | 60 | 65 | 51 | 56 | 62 |
| JRS Pharma | 57 | 61 | 61 | 60 | 51 | 50 | 57 |
| Aenova Group | 64 | 55 | 41 | 53 | 66 | 45 | 54 |
| Patheon (Thermo Fisher Scientific) | 52 | 48 | 52 | 53 | 51 | 38 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Capsugel (Lonza Group)
- Evonik Industries AG
- BASF SE
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Capsugel (Lonza Group) | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Evonik Industries AG | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| BASF SE | ✓ | ✓ | ✓ | − | ✓ | ✓ |
| Colorcon Inc. | ◐ | − | ◐ | ◐ | − | ◐ |
| Shin-Etsu Chemical Co. Ltd. | ◐ | ◐ | − | − | ◐ | − |
| JRS Pharma | ◐ | − | ◐ | ◐ | − | − |
| Aenova Group | ◐ | ◐ | − | − | − | − |
| Patheon (Thermo Fisher Scientific) | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Capsugel (Lonza Group)88
2Evonik Industries AG86
3BASF SE77
4Colorcon Inc.63
5Shin-Etsu Chemical Co. Ltd.62
6JRS Pharma57
7Aenova Group54
8Patheon (Thermo Fisher Scientific)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Capsugel (Lonza Group)Evonik Industries AG
Challenger1
Strong scale, closing on the leaders.
BASF SE
Contender3
Focused players with pockets of strength.
Colorcon Inc.Shin-Etsu Chemical Co. Ltd.JRS Pharma
Niche2
Specialists in a single segment or region.
Aenova GroupPatheon (Thermo Fisher Scientific)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across Advanced Acid-resistant Capsules Market — a $221M beachhead inside a $3.46B market.
Beachhead (SOM)$221Mobtainable near-term
Serviceable (SAM)$1.19Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Hydroxypropyl Methylcellulose (HPMC)
Best fit — highest urgency & budget in Material Type.
Economic buyer77 fit
Gelatin
Strong fit — clear ROI and a fast path to value.
End user67 fit
Pullulan
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Capsule Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel28%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Advanced Acid-resistant Capsules Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified22%
Evaluation11%
Closed-won5%
$16.3KCAC
$88KLTV
5.4:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Advanced Acid-resistant Capsules Market is a durable-growth opportunity — $9.80B by 2033, compounding at 9.8%.
TAM · 2025$4.64Btoday
TAM · 2033$9.80Bforecast
CAGR9.8%2027–2033
Cumulative$62.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.80BTotal addressable market
SAM$3.84BServiceable available market
SOM$826MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.8% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.80BLarge & growingTAM by 2033 at 9.8% CAGR
$3.84BServiceable nowreachable with today’s model
$826MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.64BBear6.4% CAGR
$9.80BBase9.8% CAGR
$12.5BBull12.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Capsule Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Advanced Acid-resistant Capsules Market — a $2.05B market by 2033. Plan: grow share from 6.3% to 13.3%.
Market size · 2033$2.05Btotal addressable
Market CAGR3.7%2027–2033
Target share13.3%from 6.3% today
Revenue ambition$273Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.3% | 13.3% | On track |
| Revenue | $137M | $273M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 38.0% | 39.1% | At risk |
| Customer retention | 87.8% | 95.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Capsule Form capability
A defensible second engine — invest in Capsule Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Capsule Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $37M capacity & capability investment
- Greenlight bolt-on M&A in Capsule Form
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Advanced Acid-resistant Capsules Market conversation — a $6.77B market you can size, segment and defend in minutes.
Market size · 2033$6.77Btotal opportunity
Growth8.3%CAGR to 2033
Addressable buyers954+accounts in scope
Typical ROI7.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.2×return on cost, year one
< 3 mopayback period
$47K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Capsugel (Lonza Group)Evonik Industries AGBASF SEColorcon Inc.Shin-Etsu Chemical Co. Ltd.JRS PharmaAenova GroupPatheon (Thermo Fisher Scientific)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Advanced Acid-resistant Capsules Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Advanced Acid-resistant Capsules Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Advanced Absorbent Wound Dressing Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportAdult Wireless Hearing Aid Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportAdult Water Flosser Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportAdult Video Endoscope Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportAdult Venturi Masks Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportAdult Ventricular Assist Device Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportAdult Urostomy Bags Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportAdult Urinary Incontinence Treatment Device Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportAdult Urinary Incontinence Implantable Device Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportAdult Treadmill Ergometer Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportAdult Tracheostomy Tubes Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportInsights-as-a-Service Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.